Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05687188 · ClinicalTrials.gov registry record
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
A clinical trial of Pancreatic Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Recruiting
- Registry status
- 125
- Enrollment target
- 2
- Study locations
NCT05687188 is a study of Pancreatic Cancer that is actively recruiting participants, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 125 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (68% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05687188, a study of Pancreatic Cancer, is actively recruiting participants, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will evaluate obesity-mediated mechanisms of pancreatic carcinogenesis in minority populations.
Conditions Studied
Interventions
- OTHER Data Collection
- OTHER Blood Sample Collection
- OTHER Tissue Sample Collection
- OTHER Medical Image Collection
Study Locations (2)
Florida
- Moffitt Cancer Center - Tampa
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2023-02-22 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05687188
The ClinicalTrials.gov registry entry for NCT05687188 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (68% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Cancer appearing as the primary indexed condition, and to 4 interventions - of which Data Collection is the first listed.
NCT05687188 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Mississippi.
Frequently Asked Questions
What is clinical trial NCT05687188 about?
NCT05687188 is a clinical study titled "Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations". This study will evaluate obesity-mediated mechanisms of pancreatic carcinogenesis in minority populations.
What is the current status of trial NCT05687188?
This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2023-02-22. Estimated completion is 2026-12.
What conditions does trial NCT05687188 study?
This clinical trial studies the following conditions: Pancreatic Cancer.
What interventions are being tested in trial NCT05687188?
The interventions under investigation include: Data Collection (OTHER), Blood Sample Collection (OTHER), Tissue Sample Collection (OTHER), Medical Image Collection (OTHER).
Who is sponsoring clinical trial NCT05687188?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05687188 being conducted?
This trial has 2 study locations across Florida, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
RECRUITING · Phase 1
-
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RECRUITING · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.